During the past decade, Madibeng Centre for Research (MCR) conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Madibeng Centre for Research (MCR)" #1 sponsor was "International Partnership for Microbicides, Inc." with 5 trials, followed by "Global Alliance for TB Drug Development" with 2 trials sponsored, "FHI 360" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Janssen Vaccines & Prevention B.V." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Madibeng Centre for Research (MCR)" #1 collaborator was "Effective Care Research Unit" with 1 trials as a collaborator, "Emavundleni Research Centre" with 1 trials as a collaborator, "Family Life Association of Swaziland" with 1 trials as a collaborator, "ICAP Columbia University" with 1 trials as a collaborator and "Kenya Medical Research Institute" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Madibeng Centre for Research (MCR)" are "HIV Infections" (5 trials), "Acquired Immunodeficiency Syndrome" (2 trials), "Contraception" (1 trials), "Drug-Resistant Tuberculosis" (1 trials) and "HIV" (1 trials). Many other conditions were trialed in "Madibeng Centre for Research (MCR)" in a lesser frequency.

Most popular intervention types in "Madibeng Centre for Research (MCR)" are "Drug" (8 trials), "Biological" (1 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Moxifloxacin" (2 trials), "Placebo" (2 trials), "Pyrazinamide" (2 trials), "dapivirine" (2 trials) and "placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Madibeng Centre for Research (MCR)" are 7 trials for "Female" genders and 3 trials for "All" genders.

Currently, there are NaN active trials in "Madibeng Centre for Research (MCR)". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Madibeng Centre for Research (MCR), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Madibeng Centre for Research (MCR), 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".